Chemodex

Terbinafine hydrochloride

CHF 150.00
In stock
CDX-T0207-G0011 gCHF 150.00
More Information
Product Details
Synonyms trans-N-(6,6-Dimethyl-2-hepten-4-ylyl)-N-methyl-1-naphthylmethylamine hydrochloride; N-[(2E)-6,6-dimethyl-2-hepten-4-yn-1-yl]-N-methyl-1-naphthalenemethanamine hydrochloride
Product Type Chemical
Properties
Formula C21H25N . HCl
MW 291.4 . 36.5
CAS 78628-80-5
RTECS QJ8600100
Source/Host Chemicals Synthetic
Purity Chemicals ≥98% (HPLC)
Appearance White to off-white powder.
Solubility Soluble in ethanol (30mg/ml), DMSO (10mg/ml), DMF (10mg/ml), methanol (50 mg/ml). Sparingly soluble in acetone or water.
Identity Determined by 1H-NMR.
Declaration Manufactured by Chemodex.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

InChi Key BWMISRWJRUSYEX-SZKNIZGXSA-N
Smiles CN(C/C=C/C#CC(C)(C)C)CC1=CC=CC2=CC=CC=C21.Cl
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage -20°C
Use/Stability Stable for at least 2 years after receipt when stored at -20°C.
Documents
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description

Terbinafine is an antifungal and antimycotic compound that is highly active against dermatophytes, mold, other basic fungi, and some strains of yeast. It is clinically used to treat nail and skin infections. Inhibits ergosterol synthesis, essential component of fungal cell membranes. Potent non-competitive inhibitor at the stage of squalene epoxidation (IC50=30nM for C. albicans). Selective activator of the K2P channel TASK3 (pEC50 = 6.2). Exhibits >10-fold selectivity for TASK3 over TREK2, TRESK, THIK1 and TASK2. Also inhibits TWIK1 (pIC50 = 5.69). K2P channels might also be a target for ist antifungal activity. Shown to exhibit at higher concentrations anti-tumor and anti-angiogenic activity by inducing cell cycle arrest, and to display interesting anti-inflammatory and free radical scavenging activities.

Product References

(1) G. Petranyi, et al.; Science 224, 1239 (1984) | (2) N.S. Ryder & M.C. Dupont; Biochem. J. 230, 765 (1985) | (3) G. Petranyi, et al.; Antimicrob. Agents Chemother. 31, 1365 (1987) | (4) N. S. Ryder, et al.; Br. J. Dermatol. 126, 39 (1992) | (5) T. Rosen, et al.; Int. J. Dermatol. 36, 788 (1997) | (6) B. Favre, et al.; Arch. Biochem. Biophys. 340, 265 (1997) | (7) C.S. Sander, et al.; Mycoses 45, 152 (2002) | (8) W.S. Lee, et al.; Int. J. Canc. 106, 125 (2003) | (9) P.Y. Ho, et al.; J. Canc. 111, 51 (2004) | (10) P.D. Wright, et al.; BBRC 493, 444 (2017)

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.